
Transgender patients and their health providers fear worsening discrimination
Kelly Houske was walking her dogs one morning when she developed stabbing pain in her back that brought her to her knees. Houske, who had survived her first heart attack only a year earlier, was worried she was experiencing a second.
When Houske arrived at a local emergency room by ambulance, she hoped for compassionate treatment. Instead, her doctor appeared cold and kept his distance, standing in the doorway without ever entering her room, Houske said.
An imaging technician ignored how much pain she was suffering and shouted at her, Houske said. Rather than help her out of the scanner, the technician barked at her to climb out of the machine herself.
'I was in so much pain I could hardly move,' said Houske, 67, whose back pain was later found to be caused by kidney stones. The technician 'kept saying, 'Come on, come on, come on,'' she recalled. 'He didn't offer to help.'
When Houske tried to stand on her own, she crumpled to the ground.
The tech stood over her impatiently, Houske said, but didn't help her off the floor. 'Eventually, someone else came into the room and helped me get up,' she said.
The 2017 encounter at a Tennessee hospital was one of many instances in which Houske, who is transgender, said she has been mistreated by a health care provider. Surveys show that mistreatment of trans patients is common — including verbal harassment or refusal of care — sometimes leading them to delay or avoid seeking care.
Many advocates for transgender people say they fear treatment of trans patients will suffer further under President Donald Trump, who has issued a slew of executive orders in recent weeks restricting transgender rights, including several that seek to limit access to transition-related health care.
In a report published in Psychiatric News last month, physicians who work with transgender patients said the executive orders have led to widespread distress among their trans patients.
And according to a report released last month from the UCLA School of Law's Williams Institute, an LGBTQ think tank, almost three-quarters of trans patients surveyed after the presidential election said they are concerned that the quality of their health care will decline under Trump. About 80% of respondents, who were surveyed before Trump took office, said they planned to make changes to their behavior, appearance or speech to downplay visibility as transgender people. One-third said they were socially isolating and avoiding public places and activities.
Shawn Reilly, a transgender community organizer in Nashville, Tennessee, said he is concerned that Trump will roll back protections for trans patients established by the Obama and Biden administrations. Reilly said they fear health providers will be allowed to withhold care from trans patients.
'Stripping transgender people and all sexual and gender minorities of protections while they are trying to access a basic human right — health care — is inhumane and unjust,' said Reilly, a former coordinator of the 'trans buddy' program at Vanderbilt University Medical Center in Nashville, which provides trained advocates to accompany transgender patients on medical visits.
Neither the Department of Health and Human Services nor the White House responded to requests for comment about the concerns of transgender people, along with their health care providers and advocates, about their treatment in health care settings.
Targeting transgender people
During his first term in office, Trump issued a policy that reversed an Obama-era nondiscrimination rule for transgender patients.
Although Trump hasn't yet issued a new rule on health care discrimination, a web page created by the Biden administration, which explained legal protections for transgender patients, is now blank.
Trump's actions in the first months of his second term have raised alarms, Reilly said.
In one of his first acts after he was inaugurated, Trump issued an executive order that denies legal recognition to transgender people. The order says that 'it is the policy of the United States to recognize two sexes, male and female. These sexes are not changeable.'
The word 'transgender' has disappeared from government websites, although some deleted web pages have been restored because of a court order. Trump has also canceled research grants for projects related to transgender health.
As part of the effort to fight what Trump calls 'gender ideology,' the Department of Veterans Affairs said last month that it will phase out coverage of gender transition care for veterans.
Through additional executive orders, Trump has tried to restrict access to gender-affirming care for transgender people under age 19, ban trans people from serving openly in the military, ban trans athletes from women's sports, require incarcerated trans women to be held in men's prisons and eliminate protections for trans students in elementary and secondary schools, such as allowing them to use the bathrooms of their choice.
Advocacy groups have challenged many of Trump's executive orders in court. Federal judges have issued temporary restraining orders on the gender-affirming care ban, the prison order and his ban on trans people enlisting or serving in the military.
Legal protections in flux
Legal protections for transgender patients are grounded in the Affordable Care Act, which bans discrimination in medical settings and health insurance based on race, color, national origin, age, disability and sex. People who have faced illegal discrimination can file complaints with the Department of Health and Human Services, which can withhold federal funds from institutions found to have violated the law.
Every president has interpreted the law differently, however. While Presidents Barack Obama and Joe Biden issued rules stating that the ban on sex discrimination also prohibits mistreatment based on sexual orientation or gender identity, Trump's first administration interpreted sex discrimination as applying only to 'the plain meaning of the word 'sex' as male or female and as determined by biology.'
Groups that disagree with those various interpretations have sued, leading judges to place sex discrimination rules issued by Obama, Biden and the first Trump administration on hold.
Anti-discrimination policies still exert powerful effects, said Elana Redfield, federal policy director at the UCLA School of Law's Williams Institute.
The Obama and Biden administrations' policies helped institute 'cultural norms requiring health providers to consider the needs of trans patients, even in places where state-level protections were not in existence yet,' Redfield said.
Trump could also cause harm by rolling back legal protections for transgender patients, Redfield said, because health care providers might feel emboldened to deny them care.
'If the federal government permits, or even condones, discrimination, it is likely that would galvanize those who already don't want to treat trans people,' Redfield said.
Without a federal rule protecting their rights, transgender patients could lose the ability to file complaints against health care providers with the Department of Health and Human Services. They could still sue health care providers or insurance companies in court, but that process is 'much more burdensome' than filing complaints with the federal health agency, Redfield said.
A small number of transgender patients have successfully sued health care providers for discrimination based on the language in the ACA, said David Stacy, vice president of government affairs for the Human Rights Campaign, which advocates for LGBTQ rights.
'It is crucial that we continue to protect transgender patients, who already face immense obstacles when accessing care,' Stacy said. 'Our leaders should be committed to ensuring that everyone can get the health care they need safely and without the fear of being mistreated.'
Some states, such as California, have their own laws protecting transgender patients from discrimination, Redfield said.
But others are already following Trump's example in restricting or trying to restrict the general rights of transgender people. In late February, Iowa struck gender identity from the state's civil rights law, making it the first state to remove civil rights from a previously protected class.
About 0.6% of U.S. adults identify as transgender, according to the Pew Research Center. Transgender patients suffer from worse physical and mental health than other patients and are less likely to have health insurance.
Houske said she can understand why some trans patients delay or avoid care.
'It's a lot of work emotionally' to see a doctor, Houske said. 'If you're doubting yourself at all, it's really hard. It's going to cause you not to seek the care you really need.'
Threats to educational efforts at hospitals
Houske said she sometimes tries to break the ice with new doctors by asking whether she is the first transgender person they have treated.
'I just try to address the elephant in the room,' said Houske, who now lives in Ohio.
Dr. Alison Haddock, president of the American College of Emergency Physicians, said health professionals should 'deliver maximally compassionate care' to all patients, including those who are transgender.
'It is absolutely foundational to emergency medicine that our door is open to anyone,' Haddock said. 'We need to make sure that we are always delivering care that is consistent with that ethos.'
Some medical schools and professional societies, such as the American College of Emergency Physicians, offer training in the health needs of LGBTQ patients, Haddock said.
'I can attest to this being a much stronger part of the curriculum than when I was in medical school,' said Haddock, who is also a dean at Washington State University's medical school.
Yet critics say medical schools aren't adequately educating the next generation of doctors to care for LGBTQ patients. Many practicing doctors say they have had little training in transgender health issues and feel unprepared to treat trans patients.. Of all the state-level medical boards in the country, only the District of Columbia's requires doctors to receive continuing education in treating LGBTQ patients, according to the Federation of State Medical Boards.
And while the American Medical Association and the American Society for Health Care Risk Management offer educational courses about LGBTQ health and reducing bias, some health care leaders say other efforts could be throttled by Trump's campaign against diversity, equity and inclusion, or DEI. Many universities and private companies, for example, are ending DEI programs for fear of losing funding or contracts.
'The political environment is making it really difficult' to include sexual orientation and gender identity in medical school courses, said Dr. Atul Grover, executive director of the Association of American Medical College's Research and Action Institute.
'We have lawmakers at the state and federal level who are convinced that incorporating the concepts of inclusion, health equity and diversity is taking away from the scientific content of what we're teaching,' Grover said. 'But it does not. These concepts aren't mutually exclusive.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
25 minutes ago
- Reuters
Drug pricing reform talks with US government lack clarity, industry executives say
June 10 (Reuters) - Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced prices will be implemented, top executives from Eli Lilly (LLY.N), opens new tab and Merck (MRK.N), opens new tab said at an industry conference on Tuesday. President Donald Trump issued an executive order last month directing drugmakers to lower the prices of their medicines to align with what other countries pay. According to the order, the administration was to set "most favored nation" price targets within 30 days. The Department of Health and Human Services has said it expects drugmakers in the U.S. to set prices for their products at the lowest price paid by other high-income countries. Lilly's chief financial officer, Lucas Montarce, said that it was not clear when a resolution on the pricing reform would be achieved. "It's hard to make any assumption about when, but they haven't shared with us any details at this time," said Montarce at the Goldman Sachs' Healthcare Conference. On Monday, Pfizer's (PFE.N), opens new tab chief executive Albert Bourla had said that the meetings with the Trump administration were focused on high-level ideas and not "digging into the substance." "Conversations are ongoing. No clarity yet on where it's going to go," said Merck's CEO Robert Davis. Davis added that Merck has discussed how to share the cost of drug innovation, both in the United States and other countries, with the administration. "But how does that all translate into an actionable plan in the near term? There's still a lot of dialog happening, so that's not as clear," he said. Lilly and Merck executives said that any pricing reforms would require regulatory changes or government-to-government actions. AbbVie's (ABBV.N), opens new tab CEO also said that there was a "long way to go" before an agreement would be reached on the pricing reform.


The Herald Scotland
13 hours ago
- The Herald Scotland
RFK Jr. fires all 17 members of CDC vaccine advisory panel
"Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," said Kennedy Jr., who has a history of controversial views on vaccines. "The public must know that unbiased science--evaluated through a transparent process and insulated from conflicts of interest--guides the recommendations of our health agencies." Kennedy Jr.'s decision marks a reversal from what a key Republican senator said the Trump Cabinet member had promised during his confirmation hearings earlier this year. Sen. Bill Cassidy, R-Louisiana, the chair of the Senate Committee on Health, Education, Labor, and Pensions, said Kennedy had promised to maintain the committee's current composition. "If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices without changes," Cassidy said. The Biden administration appointed all 17 sitting committee members, with 13 of them taking their seats in 2024. According to Trump's HHS, those appointments would have prevented the current administration from choosing a majority of the committee until 2028. "A clean sweep is necessary to reestablish public confidence in vaccine science," said Kennedy, adding that the new members "will prioritize public health and evidence-based medicine". and "no longer function as a rubber stamp for industry profit-taking agendas."


Reuters
a day ago
- Reuters
NIH scientists speak out over estimated $12 billion in Trump funding cuts
June 9 (Reuters) - Dozens of scientists, researchers and other employees at the U.S. National Institutes of Health issued a rare public rebuke Monday criticizing the Trump administration for major spending cuts that 'harm the health of Americans and people across the globe,' politicize research and 'waste public resources.' More than 60 current employees sent their letter to NIH director Dr. Jay Bhattacharya, U.S. Health Secretary Robert F. Kennedy Jr. and members of Congress who oversee NIH. Bhattacharya is scheduled to testify Tuesday at the U.S. Senate appropriations committee about his agency's budget. Overall, more than 340 current and recently terminated NIH employees signed the letter, about 250 of them anonymously. In their letter, NIH staff members said the agency had terminated 2,100 research grants totaling about $9.5 billion and an additional $2.6 billion in contracts since President Donald Trump took office Jan. 20. The contracts often support research, from covering equipment to nursing staff working on clinical trials. These terminations "throw away years of hard work and millions of dollars" and put patient health at risk, the letter said. NIH clinical trials "are being halted without regard to participant safety, abruptly stopping medications or leaving participants with unmonitored device implants." Officials at the U.S. Department of Health and Human Services, which oversees NIH, didn't immediately respond to a request for comment. In prior remarks, Bhattacharya has pledged support for Kennedy's Make America Healthy Again agenda, and he has said that means focusing the federal government's "limited resources" directly on combating chronic diseases. At his Senate confirmation hearings in March, Bhattacharya said he would ensure scientists working at NIH and funded by the agency have the necessary resources to meet its mission. NIH is the world's largest public funder of biomedical research and has long enjoyed bipartisan support from U.S. lawmakers. The Trump administration has proposed cutting $18 billion, or 40%, from NIH's budget next year, which would leave the agency with $27 billion. Nearly 5,000 NIH employees and contractors have been laid off under Kennedy's restructuring of U.S. health agencies, according to NIH staff. Dr. Jenna Norton, a program director within NIH's division of kidney, urologic and hematologic diseases, was one of 69 current employees who signed the letter as of early Monday. She said speaking out publicly was worth the risk to her career and family. "I am much more worried about the risks of not speaking up," Norton said. "There are very real concerns that we're being asked to do likely illegal activities, and certainly unethical activities that breach our rules." About 20 NIH employees who were recently terminated as probationary workers or "subject to reductions in force" added their names to the letter. In the letter, Norton and other NIH employees asked Bhattacharya to restore grants that were delayed or terminated for political reasons, where officials ignored peer review to "cater to political whims." They wrote that Bhattacharya had failed to uphold his legal duty to spend congressionally appropriated funds. One program director at the NIH's National Cancer Institute, who asked not to be identified for fear of retaliation, said she has repeatedly been asked to cancel research grants for no valid reason and in violation of agency rules. She said she fears she could become the target of lawsuits from grantees challenging those decisions. Dr. Benjamin Feldman, a staff scientist and core director at NIH's Institute of Child Health and Human Development, said he and other researchers want to work with Bhattacharya on reversing the cuts and restoring the NIH as a "beacon for science around the world." "This is really a hit to the whole enterprise of biomedical research in the United States," Feldman said. Dr. Ian Morgan, a postdoctoral fellow at the NIH, signed the letter and said he has heard from university researchers about patients losing access to novel cancer treatments in clinical trials due to the uncertainty over NIH funding. He also worries about the long-term effect from gutting NIH's investment in basic science research that can lead to lifesaving treatments years later. The NIH employees, based in Bethesda, Maryland, named their dissent the "Bethesda Declaration," modeled after Bhattacharya's Great Barrington Declaration in 2020 that called on public health officials to roll back lockdowns during the COVID-19 pandemic. "Our hope is that by modeling ourselves after the Great Barrington Declaration that maybe he'll see himself in our dissent," Norton said.